• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Aareydrugs Share Price

    Aarey Drugs & Pharmaceuticals Share PriceAarey Drugs & Pharmaceuticals

    Small Cap 6.7k Result
    ₹46.55
    As on 03 December, 2023 | 22:15 BSE: 524412 NSE: AAREYDRUGSISIN: INE198H01019

    Aarey Drugs & Pharmaceuticals Performance

    Day Range

    • Low 45.65
    • High 46.50
    ₹ 46.55

    52 Week Range

    • Low 22.00
    • High 55.90
    ₹ 46.55
    • Open Price0.00
    • Previous Close46.55
    • Volume2552

    Start SIP in Aarey Drugs & Pharmaceuticals

    Start SIP

    Aarey Drugs & Pharmaceuticals Share Price

    • Over 1 Month 11.1%
    • Over 3 Month -3.02%
    • Over 6 Month 55.95%
    • Over 1 Year 24.47%

    Aarey Drugs & Pharmaceuticals Key Statistics

    P/E Ratio 49.9
    PEG Ratio -1
    Market Cap Cr 118
    Price to Book Ratio 1
    EPS 1.5
    Dividend 0
    Relative Strength Index 44.91
    Money Flow Index 78.72
    MACD Signal 0.65
    Average True Range 1.36

    Aarey Drugs & Pharmaceuticals Investment Rating

    • Master Rating:

    • Aarey Drugs & Pharms. has an operating revenue of Rs. 329.44 Cr. on a trailing 12-month basis. An annual revenue de-growth of -15% needs improvement, Pre-tax margin of 1% needs improvement, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 24% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 28 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Aarey Drugs & Pharmaceuticals Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 58511586276117120
    Operating Expenses Qtr Cr 56501606172118118
    Operating Profit Qtr Cr 21-224-12
    Depreciation Qtr Cr 0001000
    Interest Qtr Cr 1111111
    Tax Qtr Cr 0020003
    Net Profit Qtr Cr 110031-1
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 422495
    Operating Expenses Annual Cr 411481
    Operating Profit Annual in Cr 811
    Depreciation Cr 22
    Interest Annual Cr 32
    Tax Annual Cr 23
    Net Profit Annual Cr 47
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr -1-4
    Cash from Investing Activity Annual Cr 0-2
    Cash from Financing Annual Activity Cr 16
    Net Cash Flow Annual Cr 10
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 117114
    Fixed Assets Annual Cr 1414
    Total Non Current Assets Annual Cr 2119
    Total Current Assets Annual Cr 271226
    Total Assets Annual Cr 291245
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 4645
    ROE Annual % 36
    ROCE Annual % 710
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 23
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Aarey Drugs & Pharmaceuticals

    Aarey Drugs & Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹46.55
    0 (0%)
    pointer
    • Bullish Moving Average
    • ___
    • 8
    • Bearish Moving Average
    • ___
    • 8
    • 20 Day
    • ₹47.06
    • 50 Day
    • ₹46.15
    • 100 Day
    • ₹43.82
    • 200 Day
    • ₹40.63
    • 20 Day
    • ₹47.66
    • 50 Day
    • ₹46.14
    • 100 Day
    • ₹44.46
    • 200 Day
    • ₹36.80

    Aarey Drugs & Pharmaceuticals Resistance and Support

    PIVOT
    ₹45.95
    Resistance
    First Resistance 46.25
    Second Resistance 46.80
    Third Resistance 47.10
    RSI 44.91
    MFI 78.72
    MACD Single Line 0.65
    MACD 0.40
    Support
    First Resistance 45.40
    Second Resistance 45.10
    Third Resistance 44.55

    Aarey Drugs & Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 3,399 339,900 100
    Week 6,566 656,600 100
    1 Month 36,715 3,671,471 100
    6 Month 113,035 7,678,475 67.93

    Aarey Drugs & Pharmaceuticals Result Highlights

    Aarey Drugs & Pharmaceuticals Synopsis

    NSE-Medical-Diversified

    Aarey Drugs & Ph is involved in the business activities of Activities of commission agents dealing in wholesale trade inwood, paper, skin, leather and fur, fuel, petroleum products, chemicals, perfumery and cosmetics, glass, minerals, ores and metals. Company’s Total Operating Revenue is Rs. 418.96 Cr. and Equity Capital is Rs. 25.38 Cr. for the Year ended 31/03/2023. Aarey Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/05/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1990PLC056538 and registration number is 056538.
    Market Cap 116
    Sales 329
    Shares in Float 1.27
    No of funds 3
    Yield 0.44
    Book Value 0.99
    U/D Vol ratio 1.1
    LTDebt / Equity 4
    Alpha 0.11
    Beta 0.87

    Aarey Drugs & Pharmaceuticals

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 50.04%50.04%50.04%50.03%
    Foreign Portfolio Investors 3.94%3.92%3.92%3.92%
    Individual Investors 40.61%42.24%42.24%42.41%
    Others 5.41%3.8%3.8%3.64%

    Aarey Drugs & Pharmaceuticals Management

    Name Designation
    Mr. Mihir R Ghatalia Chairman & Managing Director
    Mr. Nimit Rajesh Ghatalia Executive Director
    Ms. Archana Pramod Wani Woman Director
    Mr. Lalit Radhakrishna Tulsiani Independent Director
    Mr. Anil Mandal Independent Director
    Mr. Chetan K Mehta Independent Director

    Aarey Drugs & Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Aarey Drugs & Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2023-11-11 Quarterly Results
    2023-08-14 Quarterly Results
    2023-08-10 Preferential issue & Issue of Warrants
    2023-07-31 Preferential issue of shares
    2023-06-21 Preferential issue of shares

    Aarey Drugs & Pharmaceuticals FAQs

    What is Share Price of Aarey Drugs & Pharmaceuticals ?

    Aarey Drugs & Pharmaceuticals share price is ₹46 As on 03 December, 2023 | 22:01

    What is the Market Cap of Aarey Drugs & Pharmaceuticals ?

    The Market Cap of Aarey Drugs & Pharmaceuticals is ₹118.2 Cr As on 03 December, 2023 | 22:01

    What is the P/E ratio of Aarey Drugs & Pharmaceuticals ?

    The P/E ratio of Aarey Drugs & Pharmaceuticals is 49.9 As on 03 December, 2023 | 22:01

    What is the PB ratio of Aarey Drugs & Pharmaceuticals ?

    The PB ratio of Aarey Drugs & Pharmaceuticals is 1 As on 03 December, 2023 | 22:01

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.